--- title: "19:03 ETKnobbe Martens Delivers $381 Million Verdict for Applied Medical in Antitrust Case Against Medtronic" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/275378731.md" description: "A jury awarded Applied Medical over $381 million in an antitrust case against Medtronic, finding that Medtronic violated the Sherman Act, Clayton Act, and California Cartwright Act by monopolizing the market for advanced bipolar devices. The case, led by Knobbe Martens, highlighted issues of anticompetitive bundling and exclusive dealing that penalized hospitals for adopting competitive technologies. This verdict emphasizes the need for a competitive market in healthcare technologies." datetime: "2026-02-10T00:05:36.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/275378731.md) - [en](https://longbridge.com/en/news/275378731.md) - [zh-HK](https://longbridge.com/zh-HK/news/275378731.md) --- > 支持的语言: [English](https://longbridge.com/en/news/275378731.md) | [繁體中文](https://longbridge.com/zh-HK/news/275378731.md) # 19:03 ETKnobbe Martens Delivers $381 Million Verdict for Applied Medical in Antitrust Case Against Medtronic , /PRNewswire/ -- A team from Knobbe Martens obtained a decisive win for medical device manufacturer Applied Medical against Medtronic, Inc. in an antitrust case involving anticompetitive bundling and exclusive dealing that Applied alleged penalized hospitals for adopting competitive technologies. Applied Medical alleged that Medtronic monopolized the market for advanced bipolar devices, which are surgical devices that seal blood vessels during surgery. Following a nearly three-week trial in the U.S. District Court for the Central District of California, a jury returned a verdict awarding more than $381 million in damages to Applied Medical, finding that Medtronic violated the Sherman Act, the Clayton Act, and the California Cartwright Act. Commenting on the verdict, Knobbe Martens partner Stephen Jensen said, "Representing Applied Medical for more than two decades has been an honor, and this verdict sends a strong message: healthcare providers deserve a truly competitive market for lifesaving medical technologies free from exclusionary contractual barriers." For more information, click here. The Knobbe Martens team was led by Stephen Jensen, Stephen Larson, Joseph Re, Adam Powell, Kendall Loebakka, and Cheryl Burgess. The team also included Joe Jennings, Nick Zovko, Ben Shiroma, Nefi Oliva, Adam Copeland, and Isabella Pestana. This is the latest success for Knobbe Martens' industry-recognized litigation practice that has delivered more than $1 billion in awards to clients in high-profile cases in recent months. This includes a $634 million win in a patent infringement case against Apple in November 2025. **About Knobbe Martens' Antitrust Litigation Practice** Knobbe Martens' antitrust practice, co-chaired by Mr. Larson and Mr. Powell, leverages deep technical and IP experience to provide practical, business‑focused counsel across the full spectrum of antitrust issues involving advanced technologies. The firm litigates complex claims—from monopolization, bundling, and tying to group boycotts, conspiracies, price fixing, exclusive dealing, restraint of trade, and patent misuse—and offers strategic guidance that aligns clients' commercial goals with antitrust compliance while anticipating challenges in antitrust disputes and patent‑related counterclaims. **About Knobbe Martens** Knobbe Martens protects the ideas that drive innovation and propel our world forward. As a leading intellectual property and technology law firm, clients worldwide rely on us to safeguard their products, brands, and technologies through strategic counsel and high-impact litigation. With offices across the U.S., our lawyers and technology specialists collaborate to deliver tailored solutions for clients ranging from multinational corporations to start-ups and emerging companies at every stage. Discover more at www.knobbe.com. SOURCE Knobbe Martens ### 相关股票 - [Medtronic (MDT.US)](https://longbridge.com/zh-CN/quote/MDT.US.md) - [iShares US Medical Devices (IHI.US)](https://longbridge.com/zh-CN/quote/IHI.US.md) - [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-CN/quote/SBIO.US.md) - [SPDR S&P Health Equip (XHE.US)](https://longbridge.com/zh-CN/quote/XHE.US.md) ## 相关资讯与研究 - [Vitalist to Acquire Somatix, Pushing VitalOS Deeper Into Medical Wearables](https://longbridge.com/zh-CN/news/281221945.md) - [08:15 ETEllipsys Vascular Access System to Return to U.S. Market in 2026](https://longbridge.com/zh-CN/news/281522014.md) - [There’s Been A Staggering Number Of Deaths In ICE Custody During Trump’s Second Term](https://longbridge.com/zh-CN/news/281293924.md) - [Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures | MDT Stock News](https://longbridge.com/zh-CN/news/280796148.md) - [Inhibitor Therapeutics Provides Clinical, Formulation and IP Update on Itraconazole Program for Gorlin Syndrome | INTI Stock News](https://longbridge.com/zh-CN/news/281233776.md)